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ABSTRACT
Objective: With the spread of COVID-19 in Pakistan, Balochistan province with its unique problems of lowest literacy rates in
the country, limited resources and a ﬂail health care system is reporting an increasing number of cases of COVID-19. This study
discusses the epidemiological and clinical characteristics of COVID-19 patients from the Balochistan province.
Study Design: Situation report
Place and Duration of Study: The study was conducted in Balochistan province of Pakistan. The completion date for the
study was April 30, 2020.
Methodology: The data was retrieved from the daily situation report from the Health Department, Government of Balochistan.
Descriptive statistics (proportions, mean ± SD) were used for data analysis.
Results: A total of 1136 patients were conﬁrmed to have COVID-19. The highest rate was found in cases with ages >60 years.
About 78% of COVID-19 cases were males and majority of the cases (78.56%)were asymptomatic. Out of these, 183 recovered
and 16 died. The case fatality rate was 1.3%.
Conclusion: COVID-19 cases and case fatality ratio is low in Balochistan. Whether this is due to inability to carry out more tests
is still to be ascertained. Males and elderly are more aﬀected and fatalities were higher in cases with co-morbid conditions.
Balochistan having a weak healthcare system and with the majority of cases being asymptomatic, needs more stringent actions
to practice social distancing to avoid further spread of COVID-19.
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INTRODUCTION
A cluster of pneumonia cases of unknown origin were reported
in Wuhan, the capital city of Hubei province, China in December
2019.1
The causative agent of this pneumonia, a novel corona virus,
was isolated after a few days and sequenced, which revealed
resemblance to corona viruses such as SARS-CoV-14 and MERS-CoV-6 and was labeled SARS-CoV-2 in January 2020. 2 A disease
caused by SARS-CoV-2 was named corona virus disease 2019
(COVI-19) which has spread to 216 countries, infecting a total of
3,090,445 persons and causing outbreak associated with a new
2,3
coronavirus of probable bat origin.
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The disease has attributed to 4,287,961 cases worldwide and
the death toll globally due to COVID-19 is 288,318, as of May 12,
2020.4 COVID-19 can cause mild ﬂu-like symptoms, including
fever, cough, dyspnea, myalgia, and fatigue, while the serious
form of COVID-19 can cause acute respiratory distress
syndrome (ARDS), severe pneumonia, septic shock, and organ
failure and can lead to death.2,3
The World Health Organization (WHO) announced that COVID-19
should be characterized as a pandemic on March 11, 2020.4,5 The
total number of deaths associated with COVID-19 in Italy, Spain,
5
France, and the United States has exceeded that in China.

In Pakistan, the conﬁrmed number of cases as of May 12, 2020
was 32,674 and the death toll reached to 724 cases, with a case
fatality rate of 2.2%.4,5 The ﬁrst case of COVID-19 in Pakistan
was conﬁrmed on 26 February, 2020 by the Ministry of Health,
Government of Pakistan, in a person who had just returned from
Iran.6 The disease spread to Iran, the neighboring country of
Pakistan, from where it had spread quickly to Pakistan owing to
the thousands of pilgrims who entered from Iran to Pakistan via
Balochistan province.

Journal of the College of Physicians and Surgeons Pakistan 2021, Vol. 31 (Supplement 2 COVID-19):S104-S108

Abida Munir Badini, Aurangzeb Badini, Naeem M. Mengal and Kashmira Nanji

Balochistan received 3000 pilgrims from Iran and kept them in
quarantine center at Taftan in the ﬁrst week of March, 2020; the
numbers later exceeded 6000. The ﬁrst case of COVID-19 in
Balochistan was reported on March 10, 2020.7As of the current
situation, the number of conﬁrmed cases in Balochistan is 2061
(May 12, 2020), while the death toll is 27.8
Pakistan is a middle to low income country with a weak health
care delivery system. However, the response by the Pakistan
government has been commendable to the global COVID-19
crisis. Balochistan could have been at the center of the coronavirus outbreak as a result of the quarantine crisis at Taftan.
However, the Government of Balochistan took a timely decision
and started screening of all people crossing the borders, establishing quarantine centers, followed by closure of all educational institutes and later a lockdown in the province.

RESULTS
Screening of 26,220 people was done in Balochistan by the
health department. For the 15,335 suspected cases, 9,821
tests were conducted for conﬁrmation of COVID-19. A total of
1,136 patients were conﬁrmed to have COVID-19, while 8,685
people tested negative for the disease. The COVID-19 positivity
rate was 11.56%. From the above 1,136 patients, 183 patients
recovered and 16 died of COVID-19 in Balochistan. The active
cases from Balochistan were 937 (Figure 1).

The objective of this study was to ﬁnd out the characteristics of
patients presenting with COVID-19 in Balochistan, including
brief comment on the epidemiology and clinical features. This
study also discusses emerging COVID-19 pandemic based on
the current evidence.

METHODOLOGY
Situated in southwest of Pakistan, Balochistan province borders
Afghanistan and Iran in the west and the Arabian Sea in the
south. It accounts for nearly half of Pakistan's land mass and is
immensely rich in natural resources, including oil, gas, coal,
copper and gold. According to 2017 census data, the population
of Balochistan is 12.34 million with 6,483,653 males and
5,860,646 females.9
The study was designed as a situation report. The data was
retrieved from the oﬃcial daily situation report from the Health
Department of Government of Balochistan. The data consisted
of 9821 subjects who were suspected of having COVID-19 based
on their history of travel, exposure to a persons having
COVID-19, or having any of the symptoms of COVID-19,i.e.,
fever, cough, sore throat or shortness of breath. The data
included subjects from all districts of Balochistan. Nasal or
throat swab for COVID-19 PCR tests were conducted for conﬁrmation of having COVID-19. The completion date for the study
was April 30, 2020.
A written permission was taken from the Health Department of
Balochistan for use of the data for this study.
Statistical analysis was carried out using SPSS software (Statistical Package for the Social Sciences, version 19). Mean and
standard deviation was reported for age and proportions were
calculated for all other indicators. Case positivity rate was calculated by dividing conﬁrmed COVID cases by number of tests
conducted. Age-speciﬁc COVID-19 cases and attack rate was
reported. Attack rate was calculated by dividing the number of
COVID-19 cases in the speciﬁc age group by number of population in the speciﬁc age group per 1,000,000 population. Case
fatality rate (CFR) was calculated by dividing number of deaths
by COVID-19 with number of diagnosed COVID-19 cases.

Figure 1: COVID-19 Case Details in Balochistan (April 30th, 2020).

Figure 2: Gender Based Distribution of COVID-19 Cases in Balochistan.

The majority, 770 (93.2%), of the cases were from Quetta, the
capital city of Balochistan province, followed by small percentages from other districts surrounding Quetta.
District wise, the attack rate/1,000,000 population was highest in
Quetta (353) too, followed by Pishin (64), Sibi (62) and Khuzdar
(60).
In Quetta city, the highest attacke rate was reported in the union
council Marriabad (UC 6,7) where most people travelling to Iran
resided.
The mean age of the cases was 35 years, with the age range of
minimum of 2 months to maximum of 94 years. The most aﬀected
age group was 30-44 years (n=353:33.84%) followed by 15-29
years (n=277:26.07%). The highest attack rate (278/1,000,000
population) was reported in the age group 60+ years, followed by
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45-59 years age group (205/1,000,000 population). The overall
attack rate was 74/1,000,000 population in the Province (Table I).
Table I: Age-speciﬁc COVID-19 Cases and attack rate in Balochistan (April
30, 2020).
Age groups

Number of
conﬁrmed
cases

Percentage

93

8.90%

6715115

14

277

26.51%

2832969

98

353

33.78%

2462510

143

195

18.66%

884338

221

84

8.04%

295446

284

43

4.11%

1045

100%

13190378

79

<1-14
years
15-29
years
30-44
years
45-59
years
60 or more
Unknown
Total

Population
Attack
in age group rate/1000000

^Population of Districts are taken from 2017 censes and population of
year 2020 was calculated with growth rate of 2.6.
Table II: Clinical pattern of disease of COVID-19 patients in Balochistan.
Clinical picture

Number of cases

Percentage

Asymptomatic

821

78.56%

Fever

139

13.30%

Cough

106

10.14%

Runny nose

29

2.78%

Body ache

69

6.60%

Head ache

43

4.11%

Sore throat

36

3.44%

Rigors

2

0.19%

Shortness of breath

31

2.97%

No Information on symptoms

57

5.45%

$

Individual symptoms sum cannot be 100%

It was reported that 78% (n=817) of patients with COVID-19 were
males while 22% (n=228) were females (Figure 2).
Of the cases found to be positive, 13.78% (n=144) had a history of
international travel while local transmission accounted for
86.22% (n=901).
Majority of the patients (78.56%)who were tested positive for
COVID-19 were reported to be asymptomatic. Approximately,
13.30% presented with fever, 10.14% with cough, 6.60% had
body aches, and 3.44% sore throat.Shortness of breath was
reported to be among 2.97%.2.7% had runny nose.Rigors were
present in 0.19%and 5.45% of the patients didnot have any information of symptoms (Table II).
The mean duration of hospitalizationor test negativitywas
recorded as 19 days with a range of7 to 27 days.
The total number of people who died of COVID-19 in the province
were 16, mostly due to co-morbid conditions associated with
COVID-19. The fatalities reported from COVID-19 were associated
with; hypertension and diabetes (n=6), ARDS/COPD (n=4), renal
failure (n=3), and carcinoma (n=1). The CFR was calculated to be
1.3% in Balochistan. The recovery rate of positive cases was 16 %
(n=183).

S106

DISCUSSION
COVID-19 has rapidly spread all across Pakistan. Balochistan
province, has reported fewer cases compared to other densely
populated provinces of Pakistan.
One factor could be the lower testing capacity of Balochistan
compared to other provinces of Pakistan.10 The authors are of
the view that the total number of COVID-19 cases is likely to be
higher but under reported due to the diﬃculties in identifying
and reporting of mild and asymptomatic cases present in the
community.
The positivity rate was reported to be 11.59% in Balochistan
province, which is higher than that reported in some countries
like India and South Korea (2.6% and 2.7%, respectively) but
lower than countries like Italy (19.8% as of 20thMarch, 2020)
and Spain etc.11,12 South Korea has adopted the approach of
doing community testing, thus yielding lower positivity rates.Italy, on the other hand, carried out testing on the symptomatic
and severe cases, which might have resulted in a higher positivity rate.
While the main aﬀected group was the younger age group
(30-44 years), the attack rate was reported to be highest in the
elderly (60+ year group). This could be worrying as international studies have shown poor clinical outcomes associated
with older age and underlying co-morbidities.13
Comparable to international studies, females and children were
less aﬀected by COVID-19 in Balochistan.14 This could be due to
the fact that in some provinces of Pakistan, males are the sole
bread earners and usually go out of homes for work. The reports
from China and Italy indicate that females and children are
underrepresented, especially among severe and fatal
cases.15,16 It is still not known whether this is because of less exposure, or because they are less likely to show symptoms or are
less likely to get infected.
In contrast to previous studies, the majority of patients with
COVID-19 in Balochistan were asymptomatic.17,18 This could be
problematic, as the asymptomatic patients will continue to
infect more people without being detected. Another study
conducted in Iceland reported that 43% of the participants who
tested positive reported no symptoms.19
The CFR reported in Balochistan is lower than many countries.
Italy has a CFR of 13.59, Spain 11.40, Germany 3.9, India 3.2,
and Iran 6.3, (as of 30th April, 2020). Singapore, on the other
hand, had a CFR of 0.09.5The recovery rate of positive cases in
the province was 16%.
Many factors can confound the estimation for CFR and recovery
rate, such as, undetected cases or delayed case reporting can
signiﬁcantly aﬀect the CFR and recovery rate and thus it has to
be interpreted with caution. More research is needed to ascertain into these factors.
Mortality fromCOVID-19 was associated with co-morbids like
hypertension and diabetes in Balochistan. International data
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also show mortality in COVID-19 to be higher in patients with
underlying health conditions.14,18
Government of Balochistan has adopted unprecedented
measures to limit the spread of the virus and ﬂatten the curve.
These measures include starting screening process, establishment of quarantine centers, closing borders with neighboring
countries, closing educational institutions, imposing ban on
public gatherings and implementing province-wise lockdowns.
However, since the report shows the transmission to be local
and the cases to be asymptomatic in the area, if strict social
distancing is not practiced, the numbers could rise exponentially and the healthcare system will not be able to eﬀectively
handle the burden.
Due to the shortage of COVID-19 testing kits, we recommend
that the criteria of clinically diagnosed cases based on the
history of exposure, clinical symptoms and typical X-ray chest
(CT chest imaging if available) should be used to detect, isolate
and monitor suspected cases, thus limiting the spread, while
reserving the healthcare facilities for the more severe cases.
It is strongly recommended that medical supplies, including
personal protective equipments (PPEs), should be provided to
hospitals at district level to aid the healthcare providers in
dealing with the ever increasing cases of the COVID-19
pandemic. Besides this, invasive equipment including ventilators should be provided to divisional headquarter hospitals/
teaching hospitals of the medical colleges, so that the coming
burden of severe cases can be decreased on the tertiary care
hospital of the main cities.
COVID-19 has posed huge challenges to countries with inadequate healthcare infrastructures and lack of preparedness to
deal with such pandemic. Weak infrastructure and ﬁnancial
constraints in Pakistan are the major factors hindering response
to the current pandemic. So, the government should make
liaison with private sectors to invest in public health interventions.
Stringent policies for the implementation of public health
measures should be taken to prevent transmission of COVID-19
including wearing mask, hand washing and social distancing,
etc.
Researches should be carried out to assist the government in
shaping up COVID-19 policies.
Though the National, Provincial and District Disaster Management Authorities and the key players at the federal and provincial levels are working meticulously to address the pandemic
issue but international communities must come forward to help
the third world countries like Pakistan to help them come out of
this pandemic.

CONCLUSION
COVID-19 pandemic has challenged the healthcare system of
every country and Pakistan being a low to middle-income
country, is facing a massive task in addressing this issue.

Currently, the virus has not yet been contained and the most
terrifying situation may arise with the surge of seriously ill
patients requiring intensive care and ventilators. However, on
a positive side, this pandemic has given us the opportunity to
indeed strengthen our healthcare delivery system. Multi-sectoral interventions are required to address this public health
emergency.
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